Skip to main content
SpringerLink
Log in

Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

IgG4 comprises a significant proportion of the total anti-Fab antibody (aFABA) response in many but not all patients with rheumatoid arthritis (RA). Analyses of the dynamics of IgG aFABA subclass expression in 11 RA patients for periods of up to 11 months demonstrated that IgG4 aFABA was restricted to 6 of the 11 RA patients' sera initially studied and comprised approximately 25% (or more) of the total IgG aFABA response. Quantities of IgG4 aFABA in subsequent, serially obtained serum samples from these patients remained stable throughout the study period, whereas the remaining RA patients whose initial sera possessed small quantities of serum IgG4 aFABA failed to generate any augmented IgG4 aFABA response during the study. Elevated expression of IgG4 aFABA did not appear to be a consequence of a generalized polyclonal gammopathy or a generalized increase in autoantibody expression, though patients with higher total IgG4 serum levels expressed significantly greater quantities of IgG4 aFABA. These results indicate that the differential expression of IgG4 aFABA among RA patients reflects constitutive production within a subset of RA patients in whom IgG4 appears to comprise a significant proportion of the total IgG aFABA response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nasu H, Chia D, Knutson DW, Barnett EV (1980) Naturally occurring human antibodies to the F(ab′)2 portion of IgG. Clin Immunol 42:378–386

    Google Scholar 

  2. Silvestris F, Bankhurst AD, Searles RP, Williams RC Jr (1984) Studies of anti-F(ab′)2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosus. Arthritis Rheum 27:1387–1396

    Google Scholar 

  3. Morgan AC, Rossen RD, McCormick KJ, Stehlin JS Jr, Giovanella BC (1982) “Hidden” cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells are contained in soluble immune complexes from normal human sera. Cancer Res 42:881–887

    Google Scholar 

  4. Davey MP, Korngold L (1982) Association of anti-F(ab′)2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays. Int Arch Allergy Appl Immunol 67:278–283

    Google Scholar 

  5. Ling NR, Drysdale P (1981) Antibodies in human sera to F(ab′)2 fragments of monoclonal and polyclonal IgG. Int Arch Allergy Appl Immunol 66:459–463

    Google Scholar 

  6. Silvestris F, Williams RC Jr, Serales RP (1986) Human anti-F(ab′)2 antibodies and pepsin agglutinators react with Fv determinants. Scand J Immunol 23:499–508

    Google Scholar 

  7. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125 c:373–389

    Google Scholar 

  8. Birdsall HH, Rossen RD (1984) Regulation of antibody release by naturally occurring anti-immunoglobulins in culture of pokeweed mitogen-stimulated human peripheral blood lymphocytes. J Immunol 133:1257–1264

    Google Scholar 

  9. Persselin JE, Louie JS, Stevens RS (1984) Clonally restricted anti-IgG antibodies in rheumatoid arthritis. Arthritis Rheum 27:1378–1386

    Google Scholar 

  10. Persselin JE, Stevens RH (1985) Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G sub-classes in rheumatoid arthritis. J Clin Invest 76:723–730

    Google Scholar 

  11. Aalberse RC, Gaag R van der, Leeuwen J van (1983) Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130:722–726

    Google Scholar 

  12. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–176

    Google Scholar 

  13. Persselin JE, Keld B, Friedl L, Stevens RH (1985) Sub-classes of human IgG anti-Fab antibodies: parameters for optimum detection. Int Arch Allergy Appl Immunol 78:368–374

    Google Scholar 

  14. Sluyterman LA, Wijdenes J (1978) Chromatofocusing: isoelectric focusing on ion exchange columns. I. General principles. J Chromatogr 150:17–30

    Google Scholar 

  15. Voller A, Bidwell DE, Barlett A (1976) Enzyme-immunoassays in diagnostic medicine. Theory and practice. Bull WHO 53:55–65

    Google Scholar 

  16. Jefferis R, Reimer CB, Skvaril F et al. (1985) Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett 10:223–252

    Google Scholar 

  17. Gilbert B, Dighiero G, Avrameas S (1982) Naturally occurring antibodies against nine common antigens in normal humans. I. Detection, isolation and characterization. J Immunol 128:2779–2787

    Google Scholar 

  18. Prabhakar BS, Saegusa J, Onodera T, Notkina AL (1984) Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 133:2815–2817

    Google Scholar 

  19. Fong S, Carson DA, Vaughan JH (1985) Rheumatoid factor. In: Gupta S, Talal N (eds) Immunology of rheumatic diseases. Plenum, New York London, pp 167–196

    Google Scholar 

  20. Leibling MR, Wong C, Radosevich J (1985) Spontaneous in vitro production of anti-DNA and anti-RNA by systemic lupus erythematosus and normal peripheral blood mononuclear cells. Arthritis Rheum 28:431–440

    Google Scholar 

  21. Talal N, Pillarisetty RJ, DeHoratius RJ, Messner RP (1976) Immunologic regulation of spontaneous antibodies to DNA and RNA. I. Significance of IgM and IgG antibodies in SLE patients and asymptomatic relatives. Clin Exp Immunol 25:377–382

    Google Scholar 

  22. Sontheimer RD, Gilliam JN (1978) DNA antibody class, subclass, and complement fixation in SLE with and without nephritis. Clin Immunol Immunopathol 10:459–467

    Google Scholar 

  23. Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685

    Google Scholar 

  24. Mikkelson WM, Dodge H (1969) A 4-year follow-up of suspected rheumatoid arthritis. Arthritis Rheum 12:87–91

    Google Scholar 

  25. Williams RC, Kunkel HG (1962) Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis. J Clin Invest 41:666–675

    Google Scholar 

  26. Almeida JD, Griffith AH (1980) Viral infections and rheumatic factor. Lancet II:1361–1362

    Google Scholar 

  27. Gerardo SH, Persselin JE, Keld B, Stevens RH (1988) Anti-Fab antibodies in rheumatoid arthritis recognize a structure(s) widely distributed on human Fab molecules. Scand J Immunol (in press)

  28. Djurup R, Osterballe O (1984) IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Allergy 39:433–441

    Google Scholar 

  29. Iskander R, Das PK, Aalberse RC (1981) IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol 66:200–207

    Google Scholar 

  30. Muller-Eberhard HJ (1968) Chemistry and reaction mechanisms of complement. Adv Immunol 8:1–80

    Google Scholar 

  31. Lawrence DA, Weigle WO, Spiegelburg HL (1975) Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophil. J Clin Invest 55:368–376

    Google Scholar 

  32. Lewis EJ, Busch GJ, Schur PH (1970) Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest 49:1103–1113

    Google Scholar 

  33. Doi T, Mayumi M, Kanastu K, Suehiro F, Hamashima Y (1984) Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 58:57–62

    Google Scholar 

  34. Zee JS van der, Swieten P van, Aalberse RC (1986) Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 64:415–422

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Rheumatology, UCLA School of Medicine, 32-47 Rehabilitation Center, 90024, Los Angeles, California, USA

    J. E. Persselin

  2. Department of Microbiology and Immunology, UCLA School of Medicine, 90024, Los Angeles, California, USA

    R. H. Stevens

Authors
  1. J. E. Persselin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. H. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persselin, J.E., Stevens, R.H. Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed. Rheumatol Int 8, 205–211 (1988). https://doi.org/10.1007/BF00269196

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00269196

Key words

Search

Navigation